Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.3 appears in the page footer, replacing v3.4.2. No changes to the study record content or navigation are observed.SummaryDifference0.1%

- Check42 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1; no core trial content, outcomes, or critical information appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a Show glossary option and updated the footer text to No FEAR Act Data; the revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedThe update represents a minor version bump (Revision: v3.3.4) with no visible impact on study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.